A carregar...
A HER2 bispecific antibody can be efficiently expressed in Escherichia coli with potent cytotoxicity
Bispecific antibodies have been actively studied for cancer therapy due to their potent cytotoxicity against tumor cells. A number of bispecific antibody formats have exhibited strong tumor cytotoxicity in vitro and in vivo. However, effective production of bispecific antibodies remains challenging...
Na minha lista:
| Publicado no: | Oncol Lett |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6019972/ https://ncbi.nlm.nih.gov/pubmed/29963199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.8698 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|